Selective lysis of early embryonic cells by the alternative pathway of complement - A possible mechanism for programmed cell death in embryogenesis

In Vivo

Volumn 10, Issue 4, 1996, Pages 389-403

  Kircheis, Ralf ^a,b   Kircheis, Lilija ^a   Oshima, Haruyuki ^a   Kohchi, Chie ^a   Soma, Gen Ichiro ^a   Mizuno, Den Ichi ^a  

^a Teikyo University   (Japan)

^b Bender and Co GmbH   (Austria)

Author keywords

Complement system; Embryogenesis; Programmed cell death

Indexed keywords

COMPLEMENT; GLYCOLIPID; SIALIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOLYSIS; EMBRYO; EMBRYO CELL; EMBRYO DEVELOPMENT; ETIOLOGY; MOUSE; NONHUMAN;

EID: 0030014117     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Glücksmann A: Cell death in normal vertebrate ontogeny. Biol Rev 26: 59-86, 1951.
2. Saunders JW: Death in embryonic systems. Science 154: 604-612, 1966.
3. Oppenheim RW: Naturally occuring cell death during neural development. Trends Neurosci 8: 487-493, 1985.
4. Martin SJ: Apoptosis: suicide, execution or murder? Trends in Cell Biol. 3: 141-144, 1993.
5. Williams GT and Smith CA: Molecular regulation of apoptosis: genetic controls on cell death. Cell 74: 777-779, 1993.
6. Kerr JFR, Wyllie AH and Currie AR: Apoptosis: a basical biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
7. Schwartz LM, Smith SW, Jones MEE, and Osborne BA: Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90: 980-984, 1993.
8. Lang RA and Bishop JM: Macrophages are required for cell death and tissue remodelling in the developing mouse eye. Cell 74: 453-462, 1993.
9. Ellis HM, Yuan J, and Horvitz HR: Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817-829, 1986.
10. Hengartner MO, Ellis RE and Horvitz HR: Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494-499, 1992.
11. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, and Thomson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993.
12. Vaux DL, Weissman IL, and Kim SK: Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258: 1955-1957, 1992.
13. Yuan J, Shaham S, Ledoux S, Ellis HM, and Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1ß-converting enzyme. Cell 75: 641-652, 1993.
14. Hengartner MO, and Horvitz HR: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76: 665-676, 1994.
15. Oppenheim RW, Prevette D, Tytell M, and Homma S: Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: Evidence for the role of cell death genes. Developmental Biol 138: 104-113, 1990.
16. Raff MC: Social controls on cell survival and cell death. Nature 356: 397-400, 1992.
17. Johnson EM, Jr., and Deckwerth TL: Molecular mechanisms of developmental cell neuronal death. Annu Rev Neurosci 16: 31-46, 1993.
18. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y and Jacobson MD: Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-699, 1993.
19. Handyside AH and Hunter S: Cell division and death in the mouse blastocyst before implantation. Roux's Arch Dev Biol 795: 519-526, 1986.
20. Kohchi C, Oshima H, Mizuno D, and Soma G: Expression of transcripts of complement components and their receptors during differentiation of embryonal carcinoma cell lines. Biochem Biophys Res Commun 189 (2): 863-868, 1992.
21. Kohchi C, Noguchi K, Tanabe Y, Mizuno D, and Soma G: Constitutive expression of TNFα and -ß genes in mouse embryo: roles of cytokines as regulator and effector on development. Int J Biochem 26: 111-119, 1994.
22. Kircheis R, Kircheis L, Oshima H, Kohchi C, Soma G-I, and Mizuno D: Early embryonic cells activate the alternative complement system. In vivo 9: 85-98, 1995.
23. Robertson EJ: Embryo-derived stem cell lines. In: Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. E.J. Robertson, editor. IRL Press. Oxford, Washington DC. 71-112, 1987.
24. Hakomori S and Kannagi R: Carbohydrate antigens in higher animals. In: Handbook of Experimental Immunology. D. M. Weir, and L. Herzenberg, editors. Blackwell Scientific Publishing Inc., Boston.9.1-9.39, 1986.
25. Fearon DT: Regulation of membrane sialic acid of ß1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA. 75(4): 1971-1975, 1978.
26. Okada N, Yasuda T, and Okada H: Restriction of alternative complement pathway activation by sialosylglycolipids. Nature 299: 261-263, 1982.
27. Anderson DJ, Abbott AF, and Jack RM: The role of complement component C3b and its receptors in sperm oocyte interaction. Proc Natl Acad Sci USA 90: 10051-10055, 1993.
28. Price RJ, and Boettcher B: The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. Fertil Steril 32: 61-66, 1979.
29. Huffaker J, Witkin SS, Cutler L, Druzin ML, and Ledger WL: Total complement activity in maternal sera, amniotic fluids and cord sera in women with premature labor, premature rupture of membranes or chorioamnionitis. Surg Gynecol Obstet 168: 397-401, 1989.
30. Hunt JS: Immunobiology of pregnancy. Current Opinion in Immunology 4 (5): 591-596, 1992.
31. Meri S, and Pangburn MK: Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via sialic acid/ polyanion binding site on factor H. Proc Natl Acad Sci USA 87: 3982-3985, 1990.
32. Müller-Eberhard HJ: Molecular organization and function of the complement system. Annu Rev Biochem 57: 321-347, 1988.
33. Hs̈nsch GM: The complement attack phase: control of lysis and nonlethal effects of CSb-9. Immunopharmacol 24: 107-117, 1992.
34. Foley S, Li B, Dehoff M, Molina H, and Holers VM: Mouse Crry/65 is a regulator of the alternative pathway of complement activation. Eur J Immunol 25: 1381-1384, 1993.
35. Fingeroth JD, Benedict MA, Levy DN, and Strominger JL: Identification of milrine complement receptor type 2. Proc Natl Acad Sci USA 56: 242-246, 1989.
36. Kurtz CB, O'Toole E, Christensen SM, and Weis JH: The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 144 (9): 3581-3591, 1990.
37. Mold C, Nemerow GR, Bradt BM, and Cooper NR: CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J Immunol 140(6): 1923-1929, 1988.
38. Coulon-Morelec MJ, and Buc-Caron MH: Lipid patterns of embryonal carcinoma cell lines and their derivates: changes with differentiation. Developmental Biol 83: 278-290, 1981.